Report Overview
Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Pravastatin market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Pravastatin market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Pravastatin market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Pravastatin products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Pravastatin products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Pravastatin market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Pravastatin development has been the leading industry trend of Pravastatin market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Pravastatin Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
10mg tablet, 20mg tablet, 40mg tablet, 80mg tablet |
| By Application Outlook |
Adults, Children, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Bristol-Myers Squibb, TEVA, SANDOZ, APOTEX, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Cipla Inc., Lupin Pharmaceuticals, Glenmark, Mylan, Aurobindo Pharma, Accord Healthcare, Upsher-Smith Laboratories, Hisun, Jiangxi Boyaseehot Pharmaceutical, Shanghai Shyndec Pharmaceutical, Daiichi Sankyo, North China Pharmaceutical Group |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Bristol-Myers Squibb
- TEVA
- SANDOZ
- APOTEX
- Dr. Reddy's Laboratories
- Zydus Pharmaceuticals
- Cipla Inc.
- Lupin Pharmaceuticals
- Glenmark
- Mylan
- Aurobindo Pharma
- Accord Healthcare
- Upsher-Smith Laboratories
- Hisun
- Jiangxi Boyaseehot Pharmaceutical
- Shanghai Shyndec Pharmaceutical
- Daiichi Sankyo
- North China Pharmaceutical Group
PRAVASTATIN Market, By Type
- 10mg tablet
- 20mg tablet
- 40mg tablet
- 80mg tablet
PRAVASTATINMarket, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table Of Contents
Table of Contents
1 Pravastatin Market Overview
1.1 Pravastatin Product Overview
1.2 Pravastatin Market Segment by Type
1.2.1 10mg tablet
1.2.2 20mg tablet
1.2.3 40mg tablet
1.2.4 80mg tablet
1.3 Global Pravastatin Market Size by Type
1.3.1 Global Pravastatin Sales and Growth by Type
1.3.2 Global Pravastatin Sales and Market Share by Type (2013-2018)
1.3.3 Global Pravastatin Revenue and Market Share by Type (2013-2018)
1.3.4 Global Pravastatin Price by Type (2013-2018)
2 Global Pravastatin Market Competition by Company
2.1 Global Pravastatin Sales and Market Share by Company (2013-2018)
2.2 Global Pravastatin Revenue and Share by Company (2013-2018)
2.3 Global Pravastatin Price by Company (2013-2018)
2.4 Global Top Players Pravastatin Manufacturing Base Distribution, Sales Area, Product Types
2.5 Pravastatin Market Competitive Situation and Trends
2.5.1 Pravastatin Market Concentration Rate
2.5.2 Global Pravastatin Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Pravastatin Company Profiles and Sales Data
3.1 Bristol-Myers Squibb
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Pravastatin Product Category, Application and Specification
3.1.3 Bristol-Myers Squibb Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 TEVA
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Pravastatin Product Category, Application and Specification
3.2.3 TEVA Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 SANDOZ
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Pravastatin Product Category, Application and Specification
3.3.3 SANDOZ Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 APOTEX
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Pravastatin Product Category, Application and Specification
3.4.3 APOTEX Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 Dr. Reddy's Laboratories
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Pravastatin Product Category, Application and Specification
3.5.3 Dr. Reddy's Laboratories Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Zydus Pharmaceuticals
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Pravastatin Product Category, Application and Specification
3.6.3 Zydus Pharmaceuticals Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 Cipla Inc.
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Pravastatin Product Category, Application and Specification
3.7.3 Cipla Inc. Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 Lupin Pharmaceuticals
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Pravastatin Product Category, Application and Specification
3.8.3 Lupin Pharmaceuticals Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
3.9 Glenmark
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Pravastatin Product Category, Application and Specification
3.9.3 Glenmark Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.9.4 Main Business Overview
3.10 Mylan
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Pravastatin Product Category, Application and Specification
3.10.3 Mylan Pravastatin Sales, Revenue, Price and Gross Margin(2013-2018)
3.10.4 Main Business Overview
3.11 Aurobindo Pharma
3.12 Accord Healthcare
3.13 Upsher-Smith Laboratories
3.14 Hisun
3.15 Jiangxi Boyaseehot Pharmaceutical
3.16 Shanghai Shyndec Pharmaceutical
3.17 Daiichi Sankyo
3.18 North China Pharmaceutical Group
4 Pravastatin Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Pravastatin Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Pravastatin Sales and Revenue by Regions
4.2.1 Global Pravastatin Sales and Market Share by Regions (2013-2018)
4.2.2 Global Pravastatin Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Pravastatin Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Pravastatin Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Pravastatin Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Pravastatin Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Pravastatin Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Pravastatin Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Pravastatin Application/End Users
5.1 Pravastatin Segment by Application
5.1.1 Adults
5.1.2 Children
5.2 Global Pravastatin Product Segment by Application
5.2.1 Global Pravastatin Sales by Application
5.2.2 Global Pravastatin Sales and Market Share by Application (2013-2018)
6 Global Pravastatin Market Forecast
6.1 Global Pravastatin Sales, Revenue Forecast (2018-2025)
6.1.1 Global Pravastatin Sales and Growth Rate Forecast (2018-2025)
6.1.1 Global Pravastatin Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Pravastatin Forecast by Regions
6.2.1 North America Pravastatin Sales and Revenue Forecast (2018-2025)
6.2.2 Europe Pravastatin Sales and Revenue Forecast (2018-2025)
6.2.3 Asia-Pacific Pravastatin Sales and Revenue Forecast (2018-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Pravastatin Sales and Revenue Forecast (2018-2025)
6.2.5 Middle East and Africa Pravastatin Sales and Revenue Forecast (2018-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Pravastatin Forecast by Type
6.3.1 Global Pravastatin Sales and Revenue Forecast by Type (2018-2025)
6.3.2 10mg tablet Gowth Forecast
6.3.3 20mg tablet Gowth Forecast
6.4 Pravastatin Forecast by Application
6.4.1 Global Pravastatin Sales Forecast by Application (2018-2025)
6.4.2 Global Pravastatin Forecast in Adults
6.4.3 Global Pravastatin Forecast in Children
7 Pravastatin Upstream Raw Materials
7.1 Pravastatin Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Pravastatin Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer